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Staphylococcus aureus can establish chronic infections on implanted medical devices due to its capacity to
form biofilms. Analysis of the factors that assemble cells into a biofilm has revealed the occurrence of strains
that produce either a polysaccharide intercellular adhesin/poly-N-acetylglucosamine (PIA/PNAG) exopolysac-
charide- or a protein-dependent biofilm. Examination of the influence of matrix nature on the biofilm capac-
ities of embedded bacteria has remained elusive, because a natural strain that readily converts between a
polysaccharide- and a protein-based biofilm has not been studied. Here, we have investigated the clinical
methicillin (meticillin)-resistant Staphylococcus aureus strain 132, which is able to alternate between a pro-
teinaceous and an exopolysaccharidic biofilm matrix, depending on environmental conditions. Systematic
disruption of each member of the LPXTG surface protein family identified fibronectin-binding proteins
(FnBPs) as components of a proteinaceous biofilm formed in Trypticase soy broth-glucose, whereas a PIA/
PNAG-dependent biofilm was produced under osmotic stress conditions. The induction of FnBP levels due to
a spontaneous agr deficiency present in strain 132 and the activation of a LexA-dependent SOS response or
FnBP overexpression from a multicopy plasmid enhanced biofilm development, suggesting a direct relation-
ship between the FnBP levels and the strength of the multicellular phenotype. Scanning electron microscopy
revealed that cells growing in the FnBP-mediated biofilm formed highly dense aggregates without any detect-
able extracellular matrix, whereas cells in a PIA/PNAG-dependent biofilm were embedded in an abundant
extracellular material. Finally, studies of the contribution of each type of biofilm matrix to subcutaneous
catheter colonization revealed that an FnBP mutant displayed a significantly lower capacity to develop biofilm
on implanted catheters than the isogenic PIA/PNAG-deficient mutant.
Staphylococcus aureus is a human pathogen that causes both
nosocomial and community-acquired infections that can range
from minor skin infections to life-threatening illnesses such as
endocarditis, osteomyelitis, or toxic shock syndrome. The
emergence of highly virulent strains, resistant to many anti-
biotics, such as methicillin (meticillin)-resistant S. aureus
(MRSA) is of considerable concern worldwide (21, 24). In
addition, patients with indwelling medical devices can easily
develop staphylococcal infections, due to the ability of S. au-
reus to colonize the implant surface as a biofilm. Inside the
biofilm, bacteria are enclosed in a self-produced, hydrated
polymeric matrix that confers increased resistance to desicca-
tion and increased tolerance to antimicrobial agents and the
host immune response by mechanisms that are still somewhat
unclear.
The biofilm matrix is a complex mixture of macromolecules,
including exopolysaccharides, proteins, and DNA. The main
exopolysaccharide of the S. aureus biofilm matrix is a polymer
of poly-N-acetyl--(1-6)-glucosamine, termed polysaccharide
intercellular adhesin (PIA) or poly-N-acetylglucosamine
(PNAG), whose synthesis depends on the enzymes encoded by
the icaADBC operon (10, 19, 32). The presence of PIA/PNAG
exopolysaccharide is not essential for biofilm development,
since several studies have uncovered the existence of S. aureus
isolates able to produce alternative biofilm matrixes (6, 9, 11,
14, 28, 33, 36, 45, 46, 49). When this occurs, it appears that
proteins usually take the responsibility for mediating cell-to-
cell interactions and multicellular behavior. Interestingly, pro-
tein-mediated biofilm formation capacity seems to be particu-
larly frequent among the highly virulent MRSA isolates,
emphasizing the importance of this type of biofilm structure
(14, 37).
The first example of a surface protein able to induce biofilm
development was Bap. Bap is a large cell wall-associated pro-
tein able to mediate primary attachment to abiotic surfaces
and intercellular adhesion (11). So far, the presence of Bap has
only been described in mastitis-derived staphylococci (11, 50).
The second example was SasG, a protein involved in adhesion
to desquamated nasal epithelial cells, whose overexpression
induces the formation of peritrichous fibrils of various densi-
ties on the cell wall and biofilm development (9, 27). More
recently, two independent research groups have described a
novel S. aureus biofilm phenotype mediated by the fibronectin-
binding proteins, FnBPA and FnBPB (36, 46). Finally, we have
very recently shown that increased accumulation of protein A
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in agr mutants, and more significantly in double agr-arlRS mu-
tants, contributes to biofilm formation capacity (33, 49).
All genes encoding exopolysaccharidic and proteinaceous
factors involved in the biofilm formation process, with the
exception of bap, are widely distributed among S. aureus iso-
lates. However, as stated above, not all of these compounds
simultaneously take part in a particular biofilm, suggesting that
S. aureus regulates the production of different types of matrixes
depending on the environmental conditions. Thus, biofilm ma-
trix composition might simply depend on the availability of the
nutrients necessary to provide energy and biosynthetic inter-
mediates for the synthesis of the matrix macromolecules. As a
consequence of the environment encountered, every synthe-
sized matrix would confer specific capacities to embedded bac-
teria. In this respect, the properties that each type of biofilm
matrix bestow on the bacterial community remain unknown,
because an S. aureus strain that readily converts between po-
lysaccharidic and protein-based biofilms has not been investi-
gated.
In this study, we have identified and analyzed a MRSA S.
aureus isolate able to modulate the composition of the biofilm
matrix, producing either a PIA/PNAG- or FnBP-mediated bio-
film, depending on the environmental conditions. Interestingly,
we have demonstrated that induction of FnBP levels due to a
spontaneous agr mutation, as well as activation of the SOS
response in a LexA-dependent manner, promotes FnBP bio-
films. In addition, the analysis of the significance of each bio-
film matrix in a murine foreign-body infection model revealed
that in the case of strain 132, FnBPs played a more relevant
role than PIA/PNAG during the in vivo colonization of cath-
eters.
MATERIALS AND METHODS
Bacterial strains and growth conditions. The most relevant bacterial strains
and plasmids used in this study are listed in Table 1. The 63 ica-positive clinical
isolates tested for their capacity to form biofilms are listed in Table S1 in the
supplemental material. They were isolated at the Microbiology Department of
the Clínica Universitaria de Navarra (Pamplona, Spain) and at the Centre Na-
tional de Re´fe´rence des Staphylocoques (Hoˆpital Edouard Herriot, Lyon,
France).
Escherichia coli XL1-Blue cells were grown in Luria-Bertani (LB) broth or on
LB agar (Pronadisa, Spain). Staphylococcal strains were cultured on Trypticase
soy agar (TSA), on Congo red agar, or in Trypticase soy broth (TSB) supple-
mented with 0.25% glucose (TSB-gluc) or 3% NaCl (TSB-NaCl). Congo red agar
was prepared as follows: 30 g/liter of Trypticase soy (Pronadisa), 15 g/liter of agar
(Pronadisa), 0.8 g/liter of Congo red stain (Sigma), and 20 g/liter of sucrose. The
Congo red stain and the sucrose solution were autoclaved separately (121°C for
20 min and 115°C for 15 min, respectively). For assessment of the hemolysin
activity induced by RNAIII, sheep blood agar plates were used (Biome´rieux).
Media were supplemented with appropriate antibiotics at the following con-
centrations: erythromycin (erm) at 1.5 g ml1 or 10 g ml1; ampicillin at 100
g ml1; chloramphenicol at 5 g ml1; and tetracycline (tet) at 3 g ml1 or 125
ng ml1.
DNA manipulations. DNA plasmids were isolated from E. coli using a Bio-
Rad plasmid miniprep kit (Bio-Rad Laboratories, Inc.) according to the manu-
facturer’s protocol. Plasmids were transformed into staphylococci by electropo-
ration, using a previously described protocol (11).
Restriction enzymes were purchased from New England Biolabs and used
according to the manufacturer’s instructions. DNA polymerase was purchased
from Biotools. Oligonucleotides were obtained from Thermo Electron Corpo-
ration (see Table S2 in the supplemental material).
For detection of the icaADBC operon in S. aureus strains, the icaA and icaC
genes were amplified by PCR using primers icaA-1/icaA-2 and icaC-1/icaC-2,
respectively, (see Table S2 in the supplemental material).
For Southern hybridization, chromosomal DNA was purified, digested, and
analyzed by agarose gel electrophoresis. DNA fragments were transferred by
alkaline capillary blotting onto nylon membranes (GE Healthcare) using stan-
dard methods (3). Labeling of the probe and DNA hybridization were performed
according to the protocol supplied with the DIG DNA labeling and detection kit
(Roche).
The substitution of glutamate for glycine at the Ala-Gly cleavage site of LexA
was performed as previously described (52).
The genome of S. aureus strain 132 was sequenced using the 454 pyrosequenc-
ing strategy on a GS FLX sequencer (LifeSequencing SL, Valencia, Spain) and
resulted in the generation of 66 Mb of sequences. The GS FLX reads were
assembled into 44 large contigs longer than 1,000 bp (GenBank accession num-
ber ACOT01000000).
Allelic exchange of chromosomal genes. To generate deletion mutants, we
amplified by PCR two fragments of 500 bp that flanked the left (primers A and
B) and right (primers C and D) sequences of the genes targeted for deletion (see
Table S2 in the supplemental material). The PCR products were purified and
cloned separately in a pGEM-T Easy vector (Promega). Fragments were then
fused by ligation into the shuttle plasmid pMAD, and the resulting plasmids were
transformed into S. aureus by electroporation. pMAD contains a temperature-
sensitive origin of replication and an erythromycin resistance gene (1). Homol-
ogous recombination experiments were performed as previously described (53).
Erythromycin-sensitive white colonies, which no longer contained the pMAD
plasmid, were tested by PCR using primers E and F (see Table S2 in the
supplemental material). Deletion mutants of spa, sdrD, agr, and ica were con-
structed as previously described (33, 49, 53).
Construction of insertional mutations. For disruption of the clfA, clfB, sdrC,
sasA, sasD, sasE, sasF, sasH, sasI, sasJ, SA0927, and SA1888 genes in strain 132
(Table 1), a PCR fragment within the A regions of the different genes was
amplified using the respective primers 1 and 2 (see Table S2 in the supplemental
material) and cloned in a pGEM-T Easy vector (Promega). The corresponding
fragments were then cloned into the shuttle vector pMAD, and the resulting
plasmids were transformed into S. aureus by electroporation. The plasmids were
integrated into the chromosome through homologous recombination at a non-
permissive temperature (44°C). The disruption of the respective genes was con-
firmed by PCR using the pMAD-1 primer and the corresponding primer 3
external to each construction (see Table S2 in the supplemental material).
The srtA::ermC mutation was transduced from S. aureus Newman SKM3 (31)
into S. aureus strain 132 using phage 85. The disruption of the gene was
confirmed by PCR using primers srtA-3 and srtA-4 (see Table S2 in the supple-
mental material).
The fnbA::tet and fnbB::erm mutations were transduced from S. aureus DU
5883 (17) into S. aureus strain 132 and the 132 ica mutant using phage 85. The
disruption of the respective genes was confirmed by Southern blotting (data not
shown).
The ica::tet mutation was transduced into S. aureus strain 132 from S. aureus
SA113 ica, which contains a tetracycline resistance cassette that replaces ica
genes (10) using phage 85. All transductions were performed as described
previously (34).
Complementation experiments. For complementation experiments, the mul-
ticopy plasmids pFNBA4 and pFNBB4 (17) that carry, respectively, the wild-type
fnbA and fnbB genes of S. aureus 8325-4 were used. The empty plasmid
pALC2073 was used as a control (Table 1). For complementation of agr defi-
ciency, RNAIII was amplified by PCR using primers RNA III-1 and -2 (see Table
S2 in the supplemental material) and chromosomal DNA from strain ISP479c as
template. The PCR product was purified and cloned at the EcoRI site of the
pALC2073 plasmid, downstream of the tetracycline-inducible promoter. Correct
orientation of the insert was confirmed by restriction mapping. Expression was
induced with 125 ng ml1 of tetracycline.
Biofilm formation and detachment assays. The biofilm formation assays in
microtiter wells were performed as previously described (18). Sterile 96-well
polystyrene microtiter plates from the same manufacturer (Iwaki) were used
throughout the study. Each assay was performed in triplicate and repeated at
least three times. Crystal violet-stained cells were quantified by solubilizing the
dye with 200 l of ethanol-acetone (80:20, vol/vol) and determining the optical
density at 595 nm (OD595).
For adherence assays in a glass tube, a single colony was transferred to 5 ml of
TSB-gluc in a 15-ml tube and incubated at 37°C in an orbital shaker (250 rpm)
for 12 h.
The colony morphology of S. aureus strains was analyzed using Congo red agar
plates. Briefly, 5 l of overnight cultures of S. aureus strains were spotted onto
Congo red agar plates and incubated at 37°C for 24 h.
To test whether the activation of the SOS response induced biofilm formation,
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0.05 g/ml of mitomycin C (Sigma) was added to the growth media at the time
of inoculation.
To study biofilm formation in the presence of RNAIII, RNAIII expression by
pALC2073RNAIII was induced with 125 ng ml1 of tetracycline at the time of
inoculation.
To analyze biofilm formation under flow conditions, we used 60-ml microfer-
menters (Pasteur Institute, Laboratory of Fermentation) with a continuous 40-ml
h1 flow of medium and constant aeration with sterile compressed air (0.3 bar).
Submerged Pyrex slides served as growth substratum. Approximately 108 bacte-
ria from an overnight culture of each strain grown in the appropriate medium
were used to inoculate the microfermenters that were then kept at 37°C for 24 h.
Biofilm development was recorded with a Nikon Coolpix 950 digital camera. To
TABLE 1. Most relevant strains and plasmids used in this study
Strain or plasmid Relevant characteristic(s) Source
Strains
S. aureus
132 MRSA clinical strain; biofilm positive This study
15981 Clinical strain 53
115 Clinical strain This study
8061 Clinical strain This study
G-6478 MRSA clinical strain This study
10833 Clumping factor-positive variant of Newman D2C 10
ISP479c ISP479 cured of plasmid 38
RN4220 A mutant of S. aureus strain 8325-4 that accepts foreign DNA 35
132 ica 132 with deletion of the icaADBC operon This study
132 ica 132 ica::tet This study
132 agr 132 with deletion of the agrBDCA operon This study
132 spa 132 with deletion of the spa gene This study
132 clfA 132 clfA::pMAD This study
132 clfB 132 clfB::pMAD This study
132 fnbA 132 with deletion of the fnbA gene This study
132 fnbB 132 with deletion of the fnbB gene This study
132 fnbAB 132 with deletion of the fnbA and fnbB genes This study
132 ica fnbA 132 with deletion of the icaADBC and fnbA genes This study
132 ica fnbB 132 with deletion of the icaADBC and fnbB genes This study
132 ica fnbAB 132 with deletion of the icaADBC, fnbA, and fnbB genes This study
132 fnbAB 132 fnbA::tet fnbB::erm This study
132 ica fnbAB 132 fnbA::tet fnbB::erm with deletion of the icaADBC genes This study
132 sdrC 132 sdrC::pMAD This study
132 sdrD 132 with deletion of the sdrD gene This study
132 sdrE 132 with deletion of the sdrE gene This study
132 sasA 132 sasA::pMAD This study
132 fmtB (sasB) 132 with deletion of the fmtB gene This study
132 sasC 132 with deletion of the sasC gene This study
132 sasD 132 sasD::pMAD This study
132 sasE 132 sasE::pMAD This study
132 sasF 132 sasF::pMAD This study
132 sasG 132 with deletion of the sasG gene This study
132 sasH 132 sasH::pMAD This study
132 sasI 132 sasI::pMAD This study
132 sasJ 132 sasJ::pMAD This study
132 SA0927 132 SA0927::pMAD This study
132 SA1888 132 SA1888::pMAD This study
132 srtA 132 srtA::erm This study
132 lexA 132 LexA(G94E) This study
132 fnbAB pFNBA4 132 fnbAB complemented with the fnbA gene This study
132 fnbAB pFNBB4 132 fnbAB complemented with the fnbB gene This study
132 fnbAB pALC2073 132 fnbAB transformed with the pALC2073 plasmid This study
132 ica fnbAB pFNBA4 132 ica fnbAB complemented with the fnbA gene This study
132 ica fnbAB pFNBB4 132 ica fnbAB complemented with the fnbB gene This study
132 ica fnbAB pALC2073 132 ica fnbAB transformed with the pALC2073 plasmid This study
132 pFNBA4 132 complemented with the fnbA gene This study
132 pFNBB4 132 complemented with the fnbB gene This study
132 pALC2073 132 transformed with the pALC2073 plasmid This study
132 pALC2073RNAIII 132 transformed with the pALC2073RNAIII plasmid This study
RN4220 pFNBA4 RN4220 complemented with the fnbA gene This study
RN4220 pFNBB4 RN4220 complemented with the fnbB gene This study
RN4220 pALC2073 RN4220 transformed with the pALC2073 plasmid This study
G-6478 pFNBA4 G-6478 complemented with the fnbA gene This study
G-6478 pFNBB4 G-6478 complemented with the fnbB gene This study
G-6478 pALC2073 G-6478 transformed with the pALC2073 plasmid This study
10833 pFNBA4 10833 complemented with the fnbA gene This study
10833 pFNBB4 10833 complemented with the fnbB gene This study
10833 pALC2073 10833 transformed with pALC2073 the plasmid This study
E. coli
XL1Blue Used for cloning assays
Plasmids
pGEM-T Used for cloning assays Promega
pMAD E. coli-S. aureus shuttle vector with a thermosensitive origin of replication for gram-positive bacteria 1
pFNBA4 Vector for fnbA complementation experiments 17
pFNBB4 Vector for fnbB complementation experiments 17
pALC2073 E. coli-S. aureus shuttle vector with a tetracycline-inducible promoter. 4
pALC2073RNAIII pALC2073 with RNAIII cloned into the EcoRI site This study
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quantify the biofilm formed, bacteria adhered to the Pyrex slides were resus-
pended in 20 ml of TSB-gluc. The OD650 of the suspensions was then deter-
mined.
Biofilm detachment assays with sodium metaperiodate (Scharlau) and pro-
teinase K (Sigma) were carried out as previously described (22).
Scanning microscopy. Scanning electron microscopy was performed on bio-
films grown in microfermenters on Thermanox slides (Nalgene Nunc Interna-
tional) fixed on the internal removable glass slides, as described by Prigent-
Combaret et al. (39) at the Laboratoire de Biologie Cellulaire et Microscopie
Electronique, UFR Me´decine (Tours, France).
PIA/PNAG detection. Cell surface PIA/PNAG exopolysaccharide levels were
detected as previously described (10). Overnight cultures of the strains tested
were diluted 1:40 in the appropriate medium, and 2 ml of this cell suspension was
used to inoculate sterile 24-well polystyrene microtiter plates (Sarstedt). After
24 h of static incubation at 37°C, the same number of cells of each strain was
resuspended in 50 l of 0.5 M EDTA (pH 8.0). Then, cells were incubated for 5
min at 100°C and centrifuged to the pellet. Each supernatant (40 l) was incu-
bated with 10 l of proteinase K (20 mg/ml; Sigma) for 30 min at 37°C. After the
addition of 10 l of Tris-buffered saline (20 mM Tris-HCl, 150 mM NaCl [pH
7.4]) containing 0.01% bromophenol blue, 5 l was spotted on a nitrocellulose
filter using a Bio-Dot microfiltration apparatus (Bio-Rad), blocked overnight
with 5% skimmed milk in phosphate-buffered saline (PBS) with 0.1% Tween 20,
and incubated for 2 h with rabbit antibodies raised to S. aureus deacetylated
PNAG conjugated to diphtheria toxoid diluted at 1:10,000 (30). Bound antibod-
ies were detected with peroxidase-conjugated goat anti-rabbit immunoglobulin G
antibodies (Jackson ImmunoResearch Laboratories, Inc., Westgrove, PA), di-
luted 1:10,000, and an Amersham ECL Western blotting system.
Real-time quantitative PCR. To study the transcription of icaC and fnbB in
TSB-gluc and TSB-NaCl media, an overnight culture of strain 132 was diluted
(1:100) in the appropriate medium and grown to exponential phase (OD600 
0.6). Total S. aureus RNA was isolated using a Fast RNA-Blue kit (MP Bio-
medicals, LLC) according to the manufacturer’s instructions. In order to mini-
mize variability, nine independent RNAs were purified from each strain and
divided into three pools. RNAs were then subjected to DNase (Ambion) treat-
ment for 20 min at 37°C. After inactivation of the enzyme, and to verify the
absence of genomic DNA, the RNAs were reverse transcribed in the presence
and absence of reverse transcriptase (RT) (SuperScript III RT; Invitrogen). All
preparations were purified using Qiagen columns (QIAquick PCR purification
kit). To measure expression, icaC transcripts were amplified using primers icaC2-
SG-5 and icaC2-SG-3 and SYBR GreenER SuperMix (Invitrogen), and fnbB
transcripts were amplified using primers fnbB-FW and fnbB-RV (see Table S2 in
the supplemental material).
An ABI PRISM model 9700HT (Applied Biosystems) instrument was used to
monitor the real-time quantitative PCR. The gyrB transcripts that were consti-
tutively expressed were amplified as endogenous controls by using primers gyrB-
SG-5 and gyrB-SG-3 (see Table S2 in the supplemental material). To monitor the
specificity, final PCR products were analyzed by melting curves and electro-
phoresis. Only samples with no amplification of the minus RT aliquots were
considered in the study. The amount of icaC and fnbB transcripts was expressed
as the n-fold difference relative to the control gene (2Ct, where Ct represents
the difference in threshold cycles between the target and control genes).
Western ligand affinity blotting. For detection of the level of FnBPs after
induction of the SOS response, an overnight culture of strain 132 was diluted 1:50
in TSB-gluc medium supplemented with increasing mitomycin C concentrations
(0.005, 0.01, 0.02, 0.04, and 0.06 g/ml) and grown for 4 h, at 37°C, without
shaking. The same number of cells of each strain was collected, and surface-
associated protein extracts were prepared as previously described (2). For de-
tection of the level of FnBPs after RNAIII induction, an overnight culture of
strain 132 carrying pALC2073RNAIII was diluted 1:50 in TSB-gluc medium
supplemented with 125 ng ml1 of tetracycline, and 2 ml of this cell suspension
was used to inoculate sterile 24-well polystyrene microtiter plates (Sarstedt).
After 24 h of static incubation at 37°C, the same number of cells of each strain
was collected, and surface-associated protein extracts were prepared as previ-
ously described (2).
Electrophoretic separation of cell wall-associated protein preparations was
carried out by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE). The acrylamide concentration was 8% in the resolving gel and 4% in the
stacking gel. FnBPs were detected by Western ligand affinity blotting by incuba-
tion for 1 h with biotinylated human fibronectin (50 g/ml) in PBS containing
0.1% Tween 20 (PBST). An EZ-Link sulfo-N-hydroxysuccinimide-LC biotinyla-
tion kit (Pierce) was used to biotinylate human fibronectin (Sigma). After wash-
ing with PBST, membranes were incubated for 1 h with streptavidin-peroxidase
conjugate (Roche; 1:3,000 dilution). Finally, membranes were developed with
the ECL Western blotting system. The strain 132 fnbAB double mutant was
used as an internal negative control.
Coinfection experiments. Prior to coinfection assays, a competition experi-
ment was performed. The same number of bacteria coming from an overnight
culture of each strain was used to inoculate 5 ml of TSB-gluc. After having grown
together overnight, 100 l of an optimal dilution were plated on TSA and TSA
tet, in triplicate, in order to estimate plate counts corresponding to each strain.
To examine the in vivo interaction of fnbAB mutants with abiotic surfaces, the
murine model of catheter-associated biofilm formation described by Beenken et
al. was used with some modifications (6). Briefly, a total of 66 male Swiss mice
were anesthetized with ketamine (100 mg/kg) and xylazine (10 mg/kg). Polyure-
thane catheters (15 mm; B. Braun Medical, Bethlehem, PA) were inserted and
coinfected by injection of 200 l of a 108 CFU/ml mixture containing the same
quantity of either strain 132 and 132 fnbAB, strain 132 and 132 ica fnbAB, or
strain 132 and 132 ica. The skin of each mouse was cleansed with alcohol prior
to surgery, and as a control of the procedure, six mice were infected with sterile
PBS. Mice were euthanized at 3 or 7 days postinfection, and groups of 10 mice
were used for each comparison. The catheters were removed aseptically, washed,
and placed in 1 ml of sterile PBS. Catheters were then washed internally with the
aid of a sterile syringe and sonicated to remove adherent bacteria. The number
and identity of recovered bacteria was determined by plate count on TSA sup-
plemented with and without tetracycline at 3 g ml1. Competitive indexes were
calculated by dividing the number of tet-sensitive CFU by the number of tet-
resistant CFU.
Statistical analysis. Statistical analyses were performed with the GraphPad
Prism program. P values assessing the significance of the difference from 1 of the
competition indexes were calculated using the Wilcoxon’s test. Data correspond-
ing to gene expression were compared using the Mann-Whitney test. Differences
were considered statistically significant when P was 0.05. In the biofilm quan-
tification assays, microtiter plate data represent the means of at least nine
measures from three independent experiments.
Nucleotide sequence accession number. The 44 large contigs sequenced in this
study have been deposited in the GenBank database under accession number
ACOT01000000.
RESULTS
Selection of an S. aureus isolate able to develop PIA/PNAG-
dependent and -independent biofilms. With the aim of select-
ing a natural S. aureus isolate able to switch between the
production of a polysaccharidic and a proteinaceous biofilm
matrix depending on the environmental conditions, we first
analyzed both the capacity to form a biofilm on polystyrene
microtiter plates and the capacity to produce PIA/PNAG in
TSB-gluc in a collection of 63 ica-positive S. aureus clinical
isolates (see Table S1 in the supplemental material). The
strains were classified into four groups: (i) biofilm positive-
PIA/PNAG positive (16%); (ii) biofilm negative-PIA/PNAG
positive (36%); (iii) biofilm positive-PIA/PNAG negative
(19%); and (iv) biofilm negative-PIA/PNAG negative (29%).
Figure 1A shows the biofilm formation and PIA/PNAG pro-
duction of one representative strain from each group. Then, we
focused on group III, which contained strains that are capable
of forming a biofilm independently of PIA/PNAG synthesis
under TSB-gluc growing conditions but are perhaps able to
synthesize PIA/PNAG under conditions known to induce its
synthesis (3% NaCl and subinhibitory concentrations of anti-
biotics) (37, 41, 42). Using this approach, we selected one
isolate (MRSA strain 132) that formed a biofilm and produced
detectable levels of PIA/PNAG when NaCl (3%) was added to
the medium (Fig. 1B). To verify that PIA/PNAG was actually
required for biofilm formation under TSB-NaCl and not TSB-
gluc conditions, we generated a strain 132 icaADBC deletion
mutant and tested its biofilm formation capacity. The results
confirmed that ica deletion had no impact on the capacity of
MRSA strain 132 to produce a biofilm in TSB-gluc, whereas it
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was required for biofilm development in TSB-NaCl medium
(Fig. 2A).
We next investigated the composition of the PIA/PNAG-
independent biofilm matrix produced in TSB-gluc by means of
dispersion experiments with proteinase K and sodium metape-
riodate. The results showed that the glucose-induced biofilm
was resistant to removal by sodium metaperiodate but sensitive
to detachment by proteinase K, suggesting that a protein-
aceous compound was responsible for the glucose-induced bio-
film development (Fig. 2B). Taken together, these results al-
lowed the selection of an S. aureus strain (132) that was able to
form two types of biofilms: one that depended on PIA/PNAG
production and was formed under TSB-NaCl (3%) growth
conditions, and another one that was PIA/PNAG independent
while requiring a proteinaceous compound and was produced
under TSB-gluc incubating conditions.
Identification of the protein(s) mediating glucose-induced
biofilm development. Based on previous results showing that
different LPXTG proteins, such as Bap, SasG, and protein A,
are able to mediate biofilm development in S. aureus, we first
explored the possibility that a member of the LPXTG family of
proteins was responsible for biofilm development in TSB-gluc.
To test this hypothesis, we mutated the sortase A gene, re-
quired for the covalent anchoring of the LPXTG proteins to
the cell wall, in strain 132. The resulting mutant completely lost
the capacity to form a biofilm in TSB-gluc medium but re-
tained the ability to form a biofilm in TSB-NaCl (Fig. 3A).
These results suggested that at least one LPXTG protein was
involved in the biofilm-forming capacity of strain 132 in TSB-
gluc, whereas it had no role in PIA/PNAG-mediated biofilm
development.
Analyses of the different S. aureus sequenced genomes
showed that each isolate contains a unique repertoire of
LPXTG proteins. Additionally, some specific proteins, such as
Bap and Pls, have only been described in a few strains. In order
to determine the set of LPXTG proteins present in MRSA
strain 132, its corresponding genome was sequenced using the
454 technology. After that, we carried out the systematic mu-
tation of each of the 20 LPXTG proteins encoding the identi-
fied genes. Thereby, bap, cna, pls, and sasK were not consid-
ered in the mutagenesis protocol, since they are not present in
the genome of MRSA strain 132, and two putative LPXTG
proteins (SA0927 and SA1888) were included in the assay
(Table 1). Biofilm formation experiments of the resulting mu-
tant strains in TSB-gluc medium revealed that only deletion of
fnbB diminished the capacity of strain 132 to form a biofilm
(Fig. 3B). Considering the sequence homology between fnbB
and fnbA, we hypothesized that both proteins might be in-
FIG. 1. Selection of the S. aureus MRSA strain 132. (A) Summary of the classification of 63 ica-positive S. aureus isolates according to their
capacities to form biofilm and synthesize PIA/PNAG in TSB-gluc medium. Biofilm formation capacity on polystyrene microtiter plates after 24 h
hours of growth at 37°C in TSB-gluc medium, quantification of the biofilm formed, and dot blot analysis of the PIA/PNAG produced by one
representative S. aureus isolate of each group are shown (15981, 115, 132, and 8061). Data of OD595 represent the means of at least nine counts
from three independent experiments. Error bars show standard deviations. (B) Biofilm formation capacity on polystyrene microtiter plates,
quantification of the biofilm formed, and dot blot analysis of the PIA/PNAG accumulated by S. aureus MRSA strain 132 after 24 h hours of growth
at 37°C in TSB-gluc and TSB-NaCl media. For dot blot analysis, a 1:25 and a 1:50 dilution of the samples were spotted onto nitrocellulose
membranes, and PIA/PNAG production was detected with an anti-PIA/PNAG antiserum. OD595 data represent the means of at least nine counts
from three independent experiments. Error bars show standard deviations.
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volved in the process and that compensatory effects might
occur in single mutants. As a consequence, effects of the mu-
tation of fnbA on biofilm formation would be veiled by the
activity of FnBPB. To explore this hypothesis, a double
fnbAB mutant was constructed. Analysis of its biofilm forma-
tion capacity revealed that strain 132 fnbAB completely lost
the capacity to form a biofilm in TSB-gluc, indicating that in
this media, both FnBPB and FnBPA cooperate to produce a
biofilm (Fig. 4A). To exclude any role of PIA/PNAG exopo-
lysaccharide in the production of biofilms by single fnb mu-
tants, double ica fnbA and ica fnbB mutants as well as a
triple ica fnbAB deletion mutant were constructed, and
their biofilm-forming capacities were analyzed. The results
demonstrated no role for PIA/PNAG production in the for-
mation of the FnBP-mediated biofilm (Fig. 4A). We next in-
vestigated whether the specific requirement of FnBPs for bio-
film development in TSB-gluc and of PIA/PNAG for biofilm
development in TSB-NaCl correlated with higher fnbB/ica ex-
pression levels. For that, fnbB and icaC transcription levels in
strain 132 grown in TSB-gluc and TSB-NaCl were determined
by RT-PCR. In agreement with the observed phenotypes, the
fnbB mRNA levels were significantly higher in cells grown in
TSB-gluc than in cells grown in TSB-NaCl (Fig. 4D). In rela-
tion to icaC, despite the fact that strain 132 accumulates sig-
nificantly higher levels of PIA/PNAG exopolysaccharide in
TSB-NaCl (Fig. 1B), RT-PCR experiments did not reveal sig-
nificant differences in icaC transcriptional levels when cells
incubated in both media were analyzed (Fig. 4D), suggesting
the existence of posttranscriptional regulatory mechanisms
controlling PIA/PNAG synthesis.
Sequence analysis of the intergenic region between the fnbA
and fnbB genes revealed the existence of a small open reading
frame (ORF) (SACOL2510) encoding a protein of 40 amino
acids of unknown function that is only present in some of the
previously sequenced strains. To exclude the possibility that
the deletion of this ORF during fnbAB allelic exchange could
influence the biofilm-deficient phenotype displayed by the
fnbAB mutant, we performed a nonpolar deletion of this
ORF. The resulting mutant 132 SACOL2510 retained the
capacity to form a biofilm in both TSB-gluc and TSB-NaCl
(data not shown).
We further investigated the functionality of both FnBPA
and FnBPB in biofilm development by complementation ex-
periments. First, complementation of the double fnbAB and
triple ica fnbAB mutants with either fnbA or fnbB led to the
production of a very thick and robust biofilm, indicating that
both FnBPA and FnBPB are sufficient to promote biofilm
development when individually overexpressed in the cells (Fig.
4B). Second, overexpression of either FnBPA or FnBPB in the
wild-type strain 132 and other genetically unrelated S. aureus
strains such as RN4220, G-6478, and 10833 also resulted in a
significant induction/enhancement of the biofilm-forming ca-
pacity of these strains, demonstrating that promotion of bio-
film development by FnBPs occurs irrespective of the genetic
background (Fig. 4C). Overall, these results identified FnBPs,
among all LPXTG proteins, as essential components of the
biofilm formed by S. aureus strain 132 under TSB-gluc condi-
tions.
FnBPs induce biofilm formation under continuous-flow con-
ditions. We next investigated whether S. aureus strain 132
retained the capacity to switch between proteinaceous and
exopolysaccharidic biofilm matrixes when grown under contin-
uous-flow culture conditions in microfermenters. In agreement
with previous results, visualization of both macroscopic biofilm
development in microfermenters and biofilm cell density on
removable glass slides showed that strain 132 fnbAB lost the
capacity to form a glucose-induced biofilm but retained the
ability to produce a biofilm after 24 h of growth in TSB-NaCl.
Conversely, a 132 ica mutant lost only the capacity to form a
NaCl-induced biofilm (Fig. 5A). Together, these results indi-
cate that FnBPs are also able to promote cell-to-cell interac-
tions and biofilm formation under continuous-flow conditions
in TSB-gluc.
Next, we compared the architectures of the FnBP- and PIA/
FIG. 2. Effect of icaADBC deletion on the biofilm-forming capac-
ity of MRSA strain 132 and phenotypic characterization of the PIA/
PNAG-independent biofilm. (A) Biofilm formation of S. aureus strain
132 and its ica mutant after having grown on microtiter plates for
24 h under static conditions at 37°C in TSB-gluc and TSB-NaCl media.
To measure the biofilm formed, the amount of crystal violet-stained
cells was quantified by solubilizing the dye in ethanol/acetone and
determining the absorbance at 595 nm. Data represent the means of at
least nine counts from three independent experiments. Error bars
show standard deviations. (B) Detachment experiments. Biofilms
formed by S. aureus strain 132 after having grown in TSB-gluc for 24 h
were treated with sodium metaperiodate at 10 mM for 2 h at 37°C or
with proteinase K at 100 g/ml for 2 h at 37°C. The quantification of
the nondetached biofilm was performed as described for panel A.
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PNAG-dependent biofilm matrixes by scanning electron mi-
croscopy. For that, biofilms developed in microfermenters by
strain 132 ica in TSB-gluc medium and strain 132 fnbAB in
TSB-NaCl medium were observed. The scanning electron mi-
crographs revealed that cells growing in a FnBP-mediated bio-
film form highly dense bacterial aggregates where a close con-
tact between cells exists. The presence of extracellular matrix
surrounding the bacteria or occupying the little void space
between bacteria was undetectable (Fig. 5B). In the case of the
PIA/PNAG-dependent biofilm, cells were embedded in an
abundant extracellular matrix mesh that interconnected the
bacteria (Fig. 5B).
Role of agr in the S. aureus strain 132 biofilm formation
process. Sequence analysis of the S. aureus strain 132 genome
revealed the existence of a single nucleotide deletion on agrC
that causes a frameshift, which results in the premature inac-
tivation of the protein. Since it has been shown that transcrip-
tion of fnb genes is negatively regulated by agr (44, 56, 57), we
decided to investigate the impact of such agr deficiency on the
biofilm formation process of strain 132. For that, we comple-
mented strain 132 with the pALC2073RNAIII plasmid that
contains RNAIII under the control of a tetracycline-inducible
promoter. Expression of RNAIII was confirmed by hemolytic
activity on sheep blood agar plates (data not shown). We also
generated a complete deletion of agrBDCA to exclude any
effect of agrA on FnBP expression (40).
As shown in Fig. 6, expression of RNAIII in strain 132
reduced the FnBP levels and consequently its biofilm forma-
tion capacity in TSB-gluc, whereas it did not affect PIA/PNAG
expression and biofilm formation in TSB-NaCl. Deletion of
FIG. 3. Analyses of the contributions of the LPXTG proteins to the production of the proteinaceous biofilm formed by S. aureus strain 132.
(A) Biofilm formation capacities of S. aureus strain 132 and its srtA mutant on microtiter polystyrene plates after 24 h of static incubation in
TSB-gluc and TSB-NaCl media. (B) Biofilm formation capacities of S. aureus strain 132 and each LPXTG mutant on microtiter polystyrene plates
after 24 h of static incubation in TSB-gluc medium. Representative pictures of at least three independent assays are shown. To measure the biofilm
formed, the amount of crystal violet-stained cells was quantified by solubilizing the dye in ethanol/acetone and determining the absorbance at 595
nm. Data represent the means of at least nine counts from three independent experiments. Error bars show standard deviations.
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FIG. 4. FnBPA and FnBPB cooperate in the production of the biofilm formed in TSB-gluc. (A) Biofilm formation on microtiter polystyrene
plates after 24 h of static incubation at 37°C, in TSB-gluc medium, of single and double mutants in FnBPs in strain 132 and a strain 132 ica
background. (B) Complementation experiments. Mutants 132 fnbAB and 132 ica fnbAB were complemented with plasmid pFNBA4, which
overexpresses the fnbA gene, plasmid pFNBB4, which overexpresses the fnbB gene, or plasmid pALC2073, as a control. (C) Overexpression
experiments. Strains 132, RN4220, G-6478, and 10833 were transformed with plasmid pFNBA4, which overexpresses the fnbA gene, plasmid
pFNBB4, which overexpresses the fnbB gene, or plasmid pALC2073, as a control. Biofilm formation capacity in microtiter plates was analyzed
using TSB-gluc as a growth medium. Representative pictures of at least three independent assays are shown. wt, wild type. (D) RT-PCR analysis
of fnbB (left side) and icaC (right side) mRNA levels in S. aureus strain 132 grown in TSB-gluc or TSB-NaCl at 37°C. The gyrB transcript was used
as an endogenous control, and the results were expressed as the n-fold difference relative to the control gene (2Ct, where Ct represents the
difference in threshold cycle between the target and control genes). Significant differences were detected when fnbB transcription in TSB-gluc and
TSB-NaCl was compared (, P  0.05; n  4; Mann-Whitney test).
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agrBDCA neither affected FnBP levels nor biofilm formation
capacity compared to strain 132.
SOS response induces FnBP expression and biofilm forma-
tion. It has been described previously that LexA specifically
binds to the fnbB promoter region, repressing gene transcrip-
tion and thus protein expression until high or persistent DNA
damage occurs (7). We wondered whether activation of the
SOS response could enhance FnBP-mediated biofilm forma-
tion. To test this hypothesis, biofilm formation assays were
performed on polystyrene plates in the presence of mitomycin
C as a SOS response inductor. The biofilm formation capaci-
ties of the wild-type strain and fnbA and ica mutants in-
creased when mitomycin C (0.05 g/ml) was added to the
growth medium (Fig. 7A). As expected, such induction was
observed neither in the fnbB nor in the fnbAB mutant. To
prove that the addition of mitomycin C correlated with in-
creased FnBP expression, a Western ligand affinity blotting was
performed in the presence of increasing concentrations of mi-
tomycin C. As expected, mitomycin C induced accumulation of
FnBPs in a concentration-dependent manner (Fig. 7B).
It is known that substitution of glutamate for glycine at the
Ala-Gly LexA cleavage site results in a noncleavable repressor
[LexA(G94E)] that is less sensitive to SOS induction (29). To
confirm the role of LexA in the mitomycin C-mediated FnBP
biofilm induction, we replaced the lexA coding sequence with
the noncleavable lexA allele in the wild-type strain 132 and
found that mitomycin C was not able to induce FnBP expres-
sion and biofilm formation in the resulting mutant (Fig. 7C).
FIG. 5. Biofilm formation under continuous-flow conditions. (A) Biofilm development of wild-type S. aureus strain 132 and its fnbAB and ica
mutants in microfermenters under continuous-flow conditions in TSB-gluc or TSB-NaCl media after 24 h at 37°C. The microfermenters contained
the glass slides where bacteria formed the biofilms. The results of a representative experiment are shown. (B) Scanning electron microscopy
analysis of the biofilms developed in microfermenters. Scanning electron micrographs of the S. aureus strain 132 ica mutant grown in TSB-gluc
medium (a, c) and the strain 132 fnbAB mutant grown in TSB-NaCl medium (b, d) at 	10,000 (a, b) and 	30,000 (c, d) magnifications. Scale
bars: a and b, 2 m; c and d, 1 m.
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Together, these results demonstrate that an increase of
FnBPB expression by activation of a LexA-dependent SOS
response promotes the development of a FnBP-dependent
biofilm.
FnBPs contribute to subcutaneous catheter infection. Con-
sidering the advantage that strain 132 is able to produce at
least two types of biofilms that differ in their matrix nature, we
investigated which one, the PIA/PNAG- or the FnBP-medi-
ated biofilm, plays a more relevant role in vivo. To address this
question, a murine subcutaneous catheter infection model was
used. A total of 60 mice divided in groups of 10 were used in
the experiment. Catheters were aseptically implanted in the
subscapular spaces of the mice and coinfected with equal num-
bers of strain 132 and its corresponding fnbAB mutant, with
strain 132 and its corresponding ica mutant, and with strain 132
and its double ica fnbAB mutant. Bacteria were recovered
FIG. 6. Complementation with RNAIII reduces FnBP-mediated biofilm formation. (A) Biofilm formation on microtiter plates and FnBP levels
of S. aureus strain 132, its agr mutant, and strain 132 transformed with pALC2073RNAIII or pALC2073 empty plasmid after 24 h of static
incubation at 37°C in TSB-gluc medium. Tetracycline was added at 125 ng/ml to plasmid-containing strains to facilitate induction (upper panel).
Surface-associated protein extracts were analyzed by SDS-PAGE and detected by Western ligand affinity blotting using biotinylated human
fibronectin as a ligand (bottom panel). (B) Biofilm formation on microtiter plates and PIA/PNAG levels of S. aureus strain 132, its agr mutant,
and strain 132 transformed with pALC2073RNAIII or pALC2073 empty plasmid after 24 h of static incubation at 37°C in TSB-gluc medium.
Tetracycline was added at 125 ng/ml to plasmid-containing strains to facilitate induction (upper panel). For dot blot analysis, a 1:25 and a 1:50
dilution of the samples were spotted onto nitrocellulose membranes and PIA/PNAG production was detected with an anti-PIA/PNAG antiserum
(bottom panel).
FIG. 7. The activation of a LexA-dependent SOS response induces FnBPB expression, resulting in a reinforcement of biofilm development.
(A) Biofilm formation on microtiter plates of S. aureus strain 132 and its fnbA, fnbB, fnbAB, and ica mutants after 24 h of static incubation
at 37°C in TSB-gluc medium supplemented with or without 0.05 g/ml of mitomycin C. A representative picture of at least three independent
assays is shown. (B) Detection of FnBP levels in the presence of increasing mitomycin C concentrations. Strain 132 surface-associated protein
extracts prepared from cells grown for 4 h, in TSB-gluc medium supplemented with increasing mitomycin C concentrations, were analyzed by
SDS-PAGE and detected by Western ligand affinity blotting using biotinylated human fibronectin as a ligand. (C) Biofilm formation on microtiter
plates of S. aureus strain 132 and its lexA(G94E) mutant after 24 h of static incubation at 37°C in TSB-gluc medium supplemented with or without
0.05 g/ml of mitomycin C. A representative picture of at least three independent assays is shown.
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from implanted catheters at 3 or 7 days postinfection, and the
number of bacteria was determined by a plate count as de-
scribed in Materials and Methods. To evaluate and quantify
the contribution of each strain tested to the infection, we used
the competition index method. Using this technique, a compe-
tition index equal to 1 indicates similar virulence for both
strains, a competition index significantly greater than 1 indi-
cates a defect in virulence of the mutant strain, and a compe-
tition index significantly lower than 1 indicates the opposite.
Prior to the start of the coinfection assays, a competition ex-
periment was performed with all strains tested to confirm that
strain growth was not affected by coincubation with others.
The results showed that after 3 days, both strain 132 fnbAB
and strain 132 ica fnbAB mutants showed a significant defect
in catheter invasion in relation to the wild-type strain (Fig. 8A).
This defect became very significant after 7 days postinfection
(Fig. 8B). No significant differences were found when strain
132 ica and the wild-type strain were compared, at either 3
days or 7 days postinfection (Fig. 8).
Together, these results strongly suggest that in strain 132,
FnBPs play a more relevant role than PIA/PNAG exopolysac-
charide in the colonization of implanted devices.
DISCUSSION
One of the most unforeseen results revealed by the intense
study of the S. aureus biofilm formation process during the last
few years is the existence of surface proteins able to induce
biofilm development in the absence of exopolysaccharides. The
existence of alternative mechanisms to induce biofilm devel-
opment implies that each S. aureus isolate might have special-
ized in the development of a particular type of biofilm matrix
that would better suit the environment where it grows. Alter-
natively, different mechanisms might coexist in the same iso-
late, and thus, bacteria would make use of a particular one
depending on specific environmental conditions. In support of
the last hypothesis, a spontaneous switch to a proteinaceous
biofilm matrix in a Staphylococcus epidermidis ica::IS256 inser-
tion mutant has recently been reported (20). In our study, we
have identified and analyzed a clinical MRSA isolate able to
switch between a polysaccharidic (PIA/PNAG) and a protein-
aceous (FnBP) biofilm matrix depending on environmental
conditions. The importance of this strain lies in the possibility
of studying, on one hand, the specific properties that each
biofilm matrix bestows on bacteria and, on the other hand, the
signal transduction mechanisms involved in the modulation of
the biofilm matrix composition according to specific environ-
mental cues.
We made use of scanning electron microscopy to compare
the structures of the FnBP- and PIA/PNAG exopolysaccha-
ride-dependent biofilm matrixes. The results revealed that cells
growing in a FnBP-mediated biofilm were closely attached
without detectable extracellular matrix surrounding the bacte-
ria. In contrast, PIA/PNAG-dependent biofilms showed abun-
dant extracellular material in which bacteria were embedded.
Thus, the FnBP-dependent multicellular behavior does not fit,
sensu stricto, into the conventional biofilm definition of “a
microbially derived sessile community characterized by cells
that are irreversibly attached to a substratum or interface or to
each other and embedded in a matrix of extracellular poly-
meric substances that they have produced” (12). Taking this
into account, and considering that scanning microscopy anal-
ysis of a Bap-mediated biofilm showed similar tightly attached
bacteria (our unpublished results), we propose that a protein-
mediated biofilm should be referred to as “multicellular be-
havior.”
The versatility of the elements responsible for S. aureus
multicellular behavior is not restricted to the simple option
between a polysaccharidic or a proteinaceous component. S.
aureus cells can opt for at least four different surface proteins,
Bap, SasG, protein A, and FnBPs, to achieve protein-mediated
multicellular behavior (9, 11, 27, 33, 36, 46). Thus, the question
arises of whether the properties that the community lifestyle
confers to bacteria differ depending on the protein that pro-
motes cell-to-cell interactions. In the case of strain 132, we
performed the systematic disruption of the 20 genes encoding
LPXTG proteins present in its genome to find out the pro-
tein(s) involved in the production of a protein-mediated bio-
film formed under TSB-gluc conditions. Analysis of every mu-
FIG. 8. Comparison of the contributions of a PIA/PNAG- and a FnBP-dependent biofilm to S. aureus virulence. Competition index of fnbAB,
ica fnbAB, and ica mutants tested against the wild-type (wt) 132 strain. Catheters were coinfected with equal numbers of the strains tested, and
bacteria were recovered from implanted catheters and counted after 3 days (A) or 7 days (B) postinfection. Competition indexes were calculated
and statistical differences were determined with the Wilcoxon’s test. Horizontal bars represent the means of the competition indexes. Error bars
represent standard errors of the means. Asterisks indicate that competition indexes are significantly greater than one (, P  0.05 [significant]; ,
P  0.01 [very significant]). ns, nonsignificant differences.
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tant revealed that only the absence of FnBPs inhibited the
capacity of strain 132 to produce multicellular communities in
that medium. Thus, in the case of this particular strain and
under TSB-gluc environmental conditions, neither SasG nor
protein A seems to play any role in multicellular behavior. This
situation might simply be due to compensatory effects between
other proteins that would mask the effect of the single mutants.
Alternatively, it is likely that the laboratory conditions used in
our study might not be appropriate for inducing SasG or pro-
tein A expression to the levels required to induce a macro-
scopically noticeable multicellular behavior. In support of this
assumption, our results confirmed a direct relationship be-
tween the FnBP expression levels and the strength of the
multicellular phenotype. First, overexpression of FnBPs in
wild-type strains induced multicellular behavior. Second, the
enhanced FnBP accumulation due to the spontaneous agr mu-
tation promoted multicellular behavior. Third, induction of
FnBPB expression through activation of the SOS response
significantly increased the number of bacteria taking part of
the multicellular community. In this regard, regulation of
FnBPB expression by the SOS response has been previously
determined (7). In their study, Bisognano et al. showed that
LexA is a repressor of fnbB expression, and consequently, SOS
response induction by commonly used fluoroquinolones re-
sulted in the increased expression of the FnBPB protein on the
bacterial surface (7). As FnBPs have been shown to play an
important role during invasion of mammalian cells (47, 48) and
in mediating adherence to different host extracellular matrix
components, such as fibronectin, fibrinogen, elastin, or tro-
poelastin (23, 43, 55), an adverse consequence of SOS induc-
tion by antibiotics would be that it might facilitate colonization
of host cells and medical implants (13, 17). Accordingly, our
results suggest that an increase in FnBPB expression through
activation of the SOS response is sufficient to induce a notice-
able increase in the capacity of the strain to produce multicel-
lular communities on abiotic surfaces in vitro.
It has recently been shown that spontaneous agr mutants
frequently arise in vivo during the course of the infection (51).
Although the benefits that agr genotypic instability might pro-
vide to S. aureus in human infection remain unknown, different
studies have shown that agr mutants have a tendency to form
biofilms in vitro. Enhanced biofilm formation by agr mutants
has been attributed to (i) decreased production of RNAIII-
encoded 
-toxin, which has surfactant properties (54), (ii) de-
creased production of extracellular proteases, which can digest
the proteinaceous biofilm matrix (8), and (iii) increased accu-
mulation of protein A that promotes aggregation and cell-to-
cell interactions (33). In addition to these mechanisms, our
results indicate that the increased accumulation of FnBPs ac-
counts for another mechanism through which agr mutation can
contribute to biofilm development. A previous study investi-
gating the role of agr in clinical S. aureus MRSA isolates
reported that inactivation of agr increased ica-independent
biofilm development in 5 out of the 13 isolates investigated
(37). However, it is likely that this study underestimated the
implication of agr since some of these isolates might already be
natural agr mutants and consequently complementation with
RNAIII would be needed to determine the effects of agr on
biofilm development. Afterward, the same group demon-
strated that FnBPs were responsible for promoting biofilm
development in five genetically unrelated MRSA isolates (36).
These results suggest that MRSA isolates, like the one used in
this study, with the capacity to switch between a FnBP- and a
PIA/PNAG-based biofilm might frequently occur in clinical
settings.
To address the biological significance of PIA/PNAG and
FnBPs during colonization of implanted devices by strain 132,
we compared the capacities of the wild-type strain and the
isogenic fnbAB, ica, and ica fnbAB mutants to colonize an
implanted catheter by using a murine foreign-body infection
model. We found that the absence of FnBPs caused a signifi-
cant reduction in the capacity of the strain to colonize cathe-
ters in vivo after 3 and 7 days postinfection. In contrast, the
absence of the icaADBC operon did not lead to any significant
reduction. It is important to note that in our experimental
model, attachment of S. aureus to native implants occurred
because catheters were immediately infected after implanta-
tion without making use of a precoating period with plasma
proteins such as fibronectin. The role of PIA/PNAG exopo-
lysaccharide during the infection process has been addressed in
various studies with contradictory outcomes. Thus, PIA/PNAG
production has been described as essential for virulence in
murine models of systemic infection while deletion of the ica
locus failed to alter virulence in device-related infection mod-
els (15, 16, 25, 26). Our results are in agreement with a previ-
ous study focused on the analysis of the role of SarA in biofilm
development in vivo. In this study, Beenken et al. found that an
S. aureus UAMS-1 sarA mutant presented a reduced capacity
to colonize catheters in vivo whereas the UAMS-1 ica mutant
colonized the catheters as efficiently as the wild-type strain
using a murine model in which catheters were infected 1 h after
implantation (6). Interestingly, biofilm formation in the
UAMS-1 isolate was enhanced by coating the substrate with
plasma proteins and was not dependent on PIA/PNAG pro-
duction (5, 6). Based on these data, and taking into account
that expression of FnBPs is completely abolished in the ab-
sence of sarA (36, 46), it is tempting to speculate that the
UAMS-1 strain might produce a FnBP-dependent biofilm
whose expression would be completely abolished in the sarA
mutant strain. Thus, a reduced recovery of the sarA mutant in
coinfection experiments with implanted catheters might be due
to FnBP deficiency (6).
An association between methicillin resistance and protein-
dependent multicellular behavior in S. aureus has been postu-
lated (14, 36, 37). If such an association exists, elucidation of
the properties that FnBPs confer to the bacterial community
during the colonization of implanted medical biomaterials may
contribute to our understanding of the factors that play a role
in the persistence and transmission of MRSA isolates across
the hospitals of developed countries.
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